Anti-HSV antibody

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8889137
APP PUB NO 20130058952A1
SERIAL NO

13499429

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention relates to an anti-HSV antibody as defined in the claims, a pharmaceutical composition comprising of an effective amount of the said antibody, an expression vector comprising of a nucleotide sequence which encodes the said antibody, a host cell comprising of the said nucleotide sequence, a hybridoma cell capable of producing the said antibody and the use of the said antibody as a drug, in particular to use for the manufacture of a drug for the prophylactical or therapeutical treatment of HSV-associated diseases in a subject; as defined in the claims.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
HEIDELBERG IMMUNOTHERAPEUTICS GMBHMAX-JARECKI-STRASSE 21 HEIDELBERG 69115

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Arndt, Michaela Wilhelmsfeld, DE 7 55
Däumer, Martin P Kaiserslautern, DE 2 1
Eis-Hübinger, Anna-Maria Alfter, DE 2 1
Exner, Evelyn Nuβloch, DE 5 7
Krauss, Jürgen Wilhelmsfeld, DE 6 2
Krawczyk, Adalbert Mülheim, DE 2 1
Roggendorf, Michael Essen, DE 3 1
Schneweis, Karl Eduard Bonn, DE 2 1

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 May 18, 2026
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00